Services

Corimmun provides ELISA-based assay development on a fee-for-service basis, e. g. for the detection of drugs or other agents or for antibody detection in blood samples or other liquids.

Corimmun´s laboratories have been certified according to good laboratory practice (GLP) for these measurements.

The assays can be used for pharmacokinetic studies or antibody determinations in human or animal blood samples, e. g. during preclinical or clinical studies.

Corimmun has also received a good manufacturing practice (GMP) certificate to carry out analytical studies, and has been granted the status of a drug manufacturer.